You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OR

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Helminthes; Infestation, Intestinal Trial in Nairobi (Albendazole and Ivermectin fixed dose coformulation, Albendazole)

Recruiting
  • Helminthes; Infestation, Intestinal
  • Albendazole and Ivermectin fixed dose coformulation
  • Albendazole
  • Bahir Dar, Ethiopia
  • +2 more
Dec 16, 2022

Inflammation, Viral Replication, and Atherosclerosis in Treated

Completed
  • Atherosclerosis
    • San Francisco, California
      University of California San Francisco, San Francisco General Ho
    Nov 8, 2021

    Real-world Usage and Effectiveness of Elocta and Alprolix in

    Completed
    • Haemophilia A
    • Haemophilia B
    • Berlin, Germany
    • +21 more
    May 3, 2022

    Type2 Diabetes, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis Trial (MSDC-0602K, Placebo)

    Not yet recruiting
    • Type2 Diabetes
    • +3 more
    • (no location specified)
    Jul 8, 2021

    Obesity, Morbid, Metabolic Syndrome, Bariatric Surgery Candidate Trial in Oslo (SASI Bipartition, Gastric bypass)

    Recruiting
    • Obesity, Morbid
    • +3 more
    • SASI Bipartition
    • Gastric bypass
    • Oslo, Norway
      Aleris Hospital
    Feb 16, 2022

    Endometrial Cancers With FGFR2 Mutations Trial (FP-1039)

    Withdrawn
    • Endometrial Cancers With FGFR2 Mutations
    • (no location specified)
    Dec 9, 2021

    Dental Implants Trial in Seattle (Nobel Biocare titanium dental implants)

    Active, not recruiting
    • Dental Implants
    • Nobel Biocare titanium dental implants
    • Seattle, Washington
      the Regional Research Clinic, School of Dentistry at the Univers
    Dec 6, 2021

    Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab

    Recruiting
    • Invasive Breast Cancer
    • +3 more
    • Atlanta, Georgia
    • +7 more
    Nov 14, 2022

    Drug-Related Problems : Focus on Age and Diabetes

    Completed
    • Adverse Drug Events
    • Detection of Adverse Drug Events or Drug-Related Problems
    • Montpellier, France
      Uhmontpellier
    Oct 22, 2021

    Breast Cancer Female Trial in United Kingdom (Abemaciclib, Endocrine therapy)

    Recruiting
    • Breast Cancer Female
    • Abemaciclib
    • Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen)
    • Truro, Cornwall, United Kingdom
    • +43 more
    Jan 23, 2023

    Surgical Wound Infection Trial in Columbus (Next Science, Standard of Care)

    Recruiting
    • Surgical Wound Infection
    • Next Science
    • Standard of Care
    • Columbus, Georgia
      Piedmont Healthcare
    May 27, 2021

    Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (behavioral, other, procedure)

    Active, not recruiting
    • Recurrent Prostate Cancer
    • Stage IV Prostate Cancer
    • behavioral dietary intervention
    • +5 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Jun 3, 2022

    Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome Trial in Philadelphia (liothyronine or )

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Low Triiodothyronine Syndrome
    • liothyronine or placebo
    • Philadelphia, Pennsylvania
      Penn Medicine
    Dec 21, 2021

    Resectable, Early-stage, NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

    Completed
    Has Results
    • Resectable
    • +2 more
    • La Jolla, California
    • +17 more
    Feb 23, 2022

    Peri-Implantitis Trial in Porto Alegre (Glazing, Polishing)

    Enrolling by invitation
    • Peri-Implantitis
    • Glazing
    • Polishing
    • Porto Alegre, RS, Brazil
      Pontificia Universidade Católica do Rio Grande do Sul
    Oct 4, 2021

    Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

    Active, not recruiting
    Has Results
    • Metastatic Ewing Sarcoma
    • +9 more
    • Cabozantinib S-malate
    • Laboratory Biomarker Analysis
    • Bordeaux, France
    • +10 more
    Nov 26, 2022

    Hyperopia, Myopia Trial in Azusa (1% EXP039, Saline control)

    Enrolling by invitation
    • Hyperopia
    • Myopia
    • 1% EXP039
    • Saline control
    • Azusa, California
      Canyon City Eyecare
    May 11, 2021

    Rectal Cancer Trial (Aflibercept, 5-Fluoruracil, Oxaliplatin)

    Completed
    Has Results
    • Rectal Cancer
    • (no location specified)
    Apr 7, 2021

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Refractory or Recurrent Neuroblastoma in Children Trial (Anlotinib and irinotecan combined with temozolomide)

    Not yet recruiting
    • Refractory or Recurrent Neuroblastoma in Children
    • Anlotinib and irinotecan combined with temozolomide
    • (no location specified)
    Apr 12, 2021

    Immunocompromised, Hematologic Malignancy, Post Hematopoietic Stem Cell Transplant Trial in Toronto (High Flow Nasal Cannula or

    Active, not recruiting
    • Immunocompromised
    • +4 more
    • High Flow Nasal Cannula or Low Flow Nasal Cannula
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Apr 4, 2022

    PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

    Recruiting
    • PTCL
    • Long Beach, California
    • +2 more
    Mar 1, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Asthma, COPD Trial in London, Manchester (MGR001, CRC749 inhaler)

    Completed
    • Asthma
    • COPD
    • London, United Kingdom
    • +1 more
    Feb 22, 2022

    Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)

    Recruiting
    • Advanced Malignant Tumor
    • TQB3909 Tablets
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 3, 2022